Clinical Medications Worksheets

Generic Name Trade Name Classification Dose Route Time/frequency

Atenolol Tenormin antihypertensive 50mg PO Q day
Beta-blcoker
Peak Onset Duration Normal dosage range
2-4 hr 1hr 24 hr Antihypertensive--25-50 mg once daily; may be increased
after 2 wk to 50-100 mg once daily.
Why is your patient getting this medication For IV meds, compatibility with IV drips and/or
Management of hypertension solutions
NA
Mechanism of action and indications
(Why med ordered)
Blocks stimulation of beta1(myocardial)-
adrenergic receptors. Does not usually affect
beta2(pulmonary, vascular, uterine)-receptor sites
Nursing Implications (what to focus on)
Contraindications/warnings/interactions
Bradycardia, Diabetes mellitus (may mask signs of hypoglycemia)
Common side effects
Fatigue, weakness

D
e
c
r
e
a
s
e
d

b
l
o
o
d

p
r
e
s
s
u
r
e

a
n
d

h
e
a
r
t

r
a
t
e
Interactions with other patient drugs, OTC or Lab value alterations caused by medicine
herbal medicines (ask patient specifically) May cause increased BUN, serum lipoprotein, potassium, triglyceride,
May alter the effectiveness of insulins or oral and uric acid levels. May cause increase in blood glucose levels
hypoglycemic agents (dosage adjustments may be Be sure to teach the patient the following about this
necessary) medication
Instruct patient to take atenolol as directed at the same time each day,
even if feeling well. Patients with diabetes should closely monitor
blood glucose, especially if weakness, malaise, irritability, or fatigue
occurs. Medication does not block sweating as a sign of hypoglycemia.
Reinforce the need to continue additional therapies for hypertension
(weight loss, sodium restriction, stress reduction, regular exercise,
moderation of alcohol consumption). Medication controls but does not
cure hypertension
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this Check after giving
Monitor blood pressure, ECG, and pulse med? Decrease in blood pressure
frequently during dosage adjustment period Monitor intake and output ratios and daily
and periodically throughout therapy. weights. Assess routinely for CHF (dyspnea,
rales/crackles, weight gain, peripheral edema,
jugular venous distention)
Monitor patients receiving beta blockers for
signs of overdose (bradycardia, severe
dizziness or fainting, severe drowsiness,
dyspnea, bluish fingernails or palms,
seizures). Notify physician immediately if
these signs occur